Form D · Biotechnology
Telo Genomics Corp.
Vancouver, A1 · CIK 0001872138
Offering snapshot reported Apr 24, 2026 · SEC filing
- Reported sold
- $7.35K Offering amount: $19.1K
- Investors reported
- 1 Form D · investor count
- Minimum accepted
- $0 Reported outside-investor minimum
- First sale
- Mar 6, 2026 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Apr 24, 2026 | Initial | $7,346 | No comparison | 1 | SEC filing |
| Jan 6, 2025 | Initial | $10,420 | No comparison | 1 | SEC filing |
| Jul 15, 2021 | Initial | $80,680 | No comparison | 1 | SEC filing |
Offering details
- Securities
- Equity, Debt, Option to acquire, Security to be acquired, Other
- Exemptions
- 06b
- Duration over one year
- Yes
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-581843
Dollar amounts have been converted from Canadian dollars based on the 0.7346 Bank of Canada daily exchange rate on 3-6-26. Total Remaining to be Sold represents the aggregate exercise price of warrants sold in the United States.
Convertible debt with a conversion price of C$0.05 per common share. Detachable common share purchase warrants, each with an exercise price of C$0.08 and a term of 12 months.
Source: Form D, filed Apr 24, 2026. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Guido Baechler | Director |
| Ryan Cheung | Director |
| John Farlinger | Director, Executive |
| Sherif Louis | Executive |
| Sabine Mai | Director, Promoter |
| Ron Mc Glennen | Director |
| John Meekison | Director |
| John Price | Executive |
| Hugh Rogers | Director |
| Chris Ross | Executive |
| Christopher Ross | Executive |
Issuer details
Industry: Biotechnology (See others in industry)
Address:
1060 Quebec Street
Vancouver, A1, V6A 4K8
Vancouver, A1, V6A 4K8